好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Traditional Vascular Risk Factors Account for Different Proportions of Ischemic Stroke Within Different Gender and Race Groups
Cerebrovascular Disease and Interventional Neurology
S37 - Stroke Epidemiology: Risk Factors, Incidence, and Unique Populations (1:12 PM-1:24 PM)
002
To compare the proportion of ischemic strokes in young adults attributable to traditional vascular risk factors between genders and races.

Few studies have compared the proportion of ischemic strokes attributable to traditional vascular risk factors (population-attributable risk percent or PAR%) between genders and races. The PAR% is a function of the population prevalence and strength of association of a risk factor.

A population-based case-control study of ischemic stroke in young adults ages 18-49 in the Baltimore-Washington region was used to study the prevalence, odds ratios, and PAR% of hypertension, diabetes, and smoking among blacks and whites. Logistic regression was used to calculate age-adjusted odds ratios. All analyses were stratified by gender.

There were 1044 cases and 1099 controls. Of the cases, 47% were black, 54% were women. Roughly a quarter to a third of all strokes in women were attributable to smoking. Due to the higher prevalence of hypertension and a higher odds ratio for hypertension in black men (OR 3.9, 95% CI 2.6-5.9) compared to white men (OR 1.8, 95% CI 1.3-2.6), there was a much higher PAR% for hypertension among black men than white men.  

Traditional vascular risk factors have the potential to explain a high proportion of ischemic stroke in young adults. The high proportion of strokes in women attributable to smoking underscores the need for targeted smoking cessation interventions in this population. Diabetes and, especially, hypertension are important contributors to the excess population burden of ischemic stroke among blacks. These findings support the value of early screening and treatment for hypertension in young blacks.

Authors/Disclosures
Elizabeth M. Aradine, MD (Cleveland Clinic)
PRESENTER
No disclosure on file
Yan Hou, PhD, MB (Ayer Neuroscience Institute) No disclosure on file
No disclosure on file
Prachi Mehndiratta, MD Dr. Mehndiratta has nothing to disclose.
Seemant Chaturvedi, MD, FAHA, FAAN (University of Maryland) Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Calgary. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Ramar & Paradiso. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Cole, Scott, Kissane. The institution of Dr. Chaturvedi has received research support from NINDS.
Carolyn Cronin, MD, PhD, FAAN (University of Maryland School of Medicine) Dr. Cronin has nothing to disclose.
Michael Phipps, MD, MHS, FAAN (University of Maryland School of Medicine) Dr. Phipps has nothing to disclose.
Marcella A. Wozniak, MD, PhD (U of MD Department of Neurology) Dr. Wozniak has nothing to disclose.
Jose G. Merino, MD, MPhil, FAHA, FAAN (MedStar Georgetown University Hospital - Dept of Neurology) The institution of Dr. Merino has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Merino has received personal compensation in the range of $500-$4,999 for serving as a StrokeNet DSMB Member with National Institute of Neurological Disorders and Stroke.
Tara M. Dutta, MD (Wellspan) No disclosure on file
John Cole, MD (UMD SOM) Dr. Cole has nothing to disclose.
Steven J. Kittner, MD, MPH (Dept of Neurology) The institution of Dr. Kittner has received research support from NINDS.